IL-7: A potential next-generation adjuvant for immune cell therapies

Authors

• Richard S Hotchkiss, Washington University School of Medicine in St. Louis
• John F DiPersio, Washington University School of Medicine in St. Louis
• Cassian Yee, The University of Texas MD Anderson Cancer Center
• Russell K Pachynski, Washington University School of Medicine in St. Louis
• Marcel R M Van Den Brink, City Of Hope

Journal

Frontiers in Immunology

Publication Date

1-1-2025

Volume

16

First Page

1736931

Document Type

Open Access Publication

DOI

10.3389/fimmu.2025.1736931

Rights and Permissions

Hotchkiss RS, DiPersio JF, Yee C, Pachynski RK and Van Den Brink MRM (2026) IL-7: a potential next-generation adjuvant for immune cell therapies. Front. Immunol. 16:1736931. doi: 10.3389/fimmu.2025.1736931 © 2026 Hotchkiss, DiPersio, Yee, Pachynski and Van Den Brink. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Recommended Citation

Hotchkiss, Richard S; DiPersio, John F; Yee, Cassian; Pachynski, Russell K; and Van Den Brink, Marcel R M, "IL-7: A potential next-generation adjuvant for immune cell therapies." Frontiers in Immunology. 16, 1736931 (2025).
https://digitalcommons.wustl.edu/oa_4/7704

Department

ICTS (Institute of Clinical and Translational Sciences)